Cardinal Health
Cardinal Health, a leading global healthcare services and products company, is headquartered in the United States. Founded in 1971, the company has established itself as a key player in the healthcare industry, primarily focusing on pharmaceutical distribution and medical products. With a strong presence across North America and significant operations in Europe and Asia, Cardinal Health serves a diverse range of healthcare providers, including hospitals, pharmacies, and clinics. The company offers a comprehensive portfolio of services, including supply chain management, medication management, and clinical solutions, which are designed to enhance patient care and operational efficiency. Notably, Cardinal Health is recognised for its commitment to innovation and quality, positioning itself as a trusted partner in the healthcare ecosystem. With a robust market position, Cardinal Health continues to achieve significant milestones, reinforcing its reputation as a vital contributor to the healthcare landscape.
DitchCarbon Score
How does Cardinal Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cardinal Health's score of 65 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cardinal Health's reported carbon emissions
In 2023, Cardinal Health reported total greenhouse gas emissions of approximately 38,316,000 kg CO2e, comprising 163,044,000 kg CO2e from Scope 1 and 220,684,000 kg CO2e from Scope 2 emissions. Additionally, Scope 3 emissions accounted for about 21,363,272,000 kg CO2e, highlighting the significant impact of their supply chain and operational activities. Cardinal Health has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50% by FY2030, using FY2019 as the baseline year. Furthermore, the company plans for 75% of its suppliers, based on spend, to establish science-based targets by FY2028. This commitment aligns with industry standards and reflects a proactive approach to addressing climate change. The company has consistently reported emissions data, with a notable decrease in Scope 1 and 2 emissions from 438,879,000 kg CO2e in 2019 to 383,728,000 kg CO2e in 2023. This reduction demonstrates Cardinal Health's ongoing efforts to enhance sustainability within its operations and supply chain.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 335,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 177,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 0,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cardinal Health is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
